Select Medical Holdings Corporation (SEM)
NYSE: SEM · IEX Real-Time Price · USD
28.45
+0.47 (1.68%)
May 2, 2024, 4:00 PM EDT - Market closed
Select Medical Holdings Revenue
Select Medical Holdings had revenue of $6.79B in the twelve months ending March 31, 2024, with 6.08% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.79B with 7.44% year-over-year growth. In the year 2023, Select Medical Holdings had annual revenue of $6.66B with 5.22% growth.
Revenue (ttm)
$6.79B
Revenue Growth
+6.08%
P/S Ratio
0.54
Revenue / Employee
$124,320
Employees
54,600
Market Cap
3.65B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6.66B | 330.52M | 5.22% |
Dec 31, 2022 | 6.33B | 129.02M | 2.08% |
Dec 31, 2021 | 6.20B | 672.80M | 12.16% |
Dec 31, 2020 | 5.53B | 77.79M | 1.43% |
Dec 31, 2019 | 5.45B | 372.66M | 7.33% |
Dec 31, 2018 | 5.08B | 716.01M | 16.40% |
Dec 31, 2017 | 4.37B | 147.79M | 3.50% |
Dec 31, 2016 | 4.22B | 474.72M | 12.68% |
Dec 31, 2015 | 3.74B | 677.72M | 22.11% |
Dec 31, 2014 | 3.07B | 89.37M | 3.00% |
Dec 31, 2013 | 2.98B | 26.68M | 0.90% |
Dec 31, 2012 | 2.95B | 144.46M | 5.15% |
Dec 31, 2011 | 2.80B | 414.22M | 17.33% |
Dec 31, 2010 | 2.39B | 150.42M | 6.72% |
Dec 31, 2009 | 2.24B | 86.51M | 4.02% |
Dec 31, 2008 | 2.15B | 161.70M | 8.12% |
Dec 31, 2007 | 1.99B | 140.17M | 7.57% |
Dec 31, 2006 | 1.85B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Oscar Health | 5.86B |
PACS Group | 3.11B |
Integer Holdings | 1.63B |
RadNet | 1.62B |
Prestige Consumer Healthcare | 1.13B |
Ultragenyx Pharmaceutical | 434.25M |
Insmed | 305.21M |
Axsome Therapeutics | 270.60M |
SEM News
- 15 hours ago - Select Medical Holdings Corporation Announces Results For Its First Quarter Ended March 31, 2024 and Cash Dividend - PRNewsWire
- 27 days ago - Select Medical Holdings Corporation to Announce First Quarter 2024 Results on Thursday, May 2, 2024 - PRNewsWire
- 4 weeks ago - SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Select Medical Holdings Corporation (NYSE: SEM) - PRNewsWire
- 6 weeks ago - Concentra Announces Confidential Submission of Draft Registration Statement Related to Proposed Public Offering - PRNewsWire
- 2 months ago - Select Medical Holdings Corporation Receives Favorable IRS Private Letter Ruling on Tax-Free Nature of Its Previously Announced Potential Separation of Concentra - PRNewsWire
- 2 months ago - Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2023 and Cash Dividend - PRNewsWire
- 3 months ago - Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2023 Results on Thursday, February 22, 2024 - PRNewsWire
- 4 months ago - Select Medical Holdings Corporation Announces Potential Separation of Concentra - PRNewsWire